Cumulative preferreds offer a compelling solution for income-focused investors, especially in uncertain and challenging ...

The two-week-old preferred shares issued by Michael Saylor-led Strategy Inc. (NASDAQ:MSTR) have been seven times more liquid, ...

Strategic Financial Concepts LLC purchased a new position in Flaherty & Crumrine Preferred Securities Income Fund Inc. (NYSE:FFC – Free Report) during the fourth quarter, according to the company in ...

Hammond Power Solutions (TSE:HPS – Get Free Report) was upgraded by stock analysts at Cormark to a “moderate buy” rating in a note issued to investors on Tuesday,Zacks.com reports. Hammond Power ...

Discover two undervalued dividend stocks challenging the 60/40 rule. Enjoy strong returns, inflation protection & income ...

We recently compiled a list of the Top 14 AI Stocks on Wall Street: News and Analyst Ratings. In this article, we are going ...

Exchange-traded funds, or ETFs, are a convenient and cost-effective way for investors to own a diversified, professionally ...

Nuvama suggested 'Buy' on Muthoot Finance, SBI Card, Ashoka Buildcon, Whirlpool of India, Cummins India, SAIL and DRL. It was ...

Earn a top-notch APY with LendingClub's LevelUp Savings account -- no fees and no minimum deposit required. Discover how this HYSA can work for you.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Macquarie suggested a target price of Rs 7,400 for Divis Labs, Rs 1,500 for Suven Pharma, Rs 835 for Syngene and Rs 1,000 for Blue Jet Healthcare, suggesting 19-35 per cent upside potential.